ZIMMER BIOMET HOLDINGS, INC. Business Acquisition, Pro Forma Revenue
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Business Acquisition, Pro Forma Revenue of $7.52 billion for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-27.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2018-02-27
- ZIMMER BIOMET HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2015-12-31 was $1.93B, a 6.09% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2015-09-30 was $1.76B, a 6.68% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2015-06-30 was $1.88B, a 6.76% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2014-12-31 was $2.06B.
- ZIMMER BIOMET HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2015 was $7.52B, a 5.62% decline from fiscal 2014.
- ZIMMER BIOMET HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2014 was $7.97B.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 6 month as first filed | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2015-12-31 | $1.93B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.70B derived: sum of 2 quarters · filed 2018-02-27 | $5.58B derived: sum of 3 quarters · filed 2018-02-27 | $7.52B 10-K · filed 2018-02-27 | $7.52B 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $1.76B 10-Q · filed 2015-11-09 | $3.64B derived: sum of 2 quarters · filed 2016-08-08 | $5.58B 10-Q · filed 2016-11-08 | ||||
| 2015-06-30 | $1.88B 10-Q · filed 2016-08-08 | $1.89B 10-Q · filed 2015-08-10 | $3.82B 10-Q · filed 2016-08-08 | $3.83B 10-Q · filed 2015-08-10 | |||
| 2014-12-31 | $2.06B derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.95B derived: sum of 2 quarters · filed 2017-03-01 | $5.96B derived: sum of 3 quarters · filed 2017-03-01 | $7.97B 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $1.89B 10-Q · filed 2015-11-09 | $3.90B derived: sum of 2 quarters · filed 2015-11-09 | $5.91B 10-Q · filed 2015-11-09 | ||||
| 2014-06-30 | $2.02B 10-Q · filed 2015-08-10 | $4.02B 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |